Therapeutic Area
Infectious Disease
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
BMJ Journals
Infectious Disease
Platform
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial
July 15, 2025
DOI: 10.1136/thorax-2024-222488
Springer Nature
Infectious Disease
Meta-analysis
Corticosteroids for adult patients hospitalised with non-viral community-acquired pneumonia: a systematic review and meta-analysis
May 5, 2025
DOI:10.1007/s00134-025-07912-2
Springer Nature
Infectious Disease
Platform
Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial
April 22, 2025
DOI: 10.1007/s00134-025-07861-w
Springer Nature
Infectious Disease
Platform
Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trial
February 11, 2025
DOI: 10.1186/s13063-024-08684-8
Annals of Internal Medicine
Infectious Disease
Meta-analysis
Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis
January 17, 2025
DOI: 10.7326/ANNALS-24-00800
Trials Journal
Infectious Disease
Platform
A blueprint for a multi-disease, multi-domain Bayesian adaptive platform trial incorporating adult and paediatric subgroups: the Staphylococcus aureus Network Adaptive Platform trial
December 6, 2024
doi: 10.1186/s13063-023-07718-x.
Clinical Infectious Disease
Infectious Disease
Platform
Does Adjunctive Clindamycin Have a Role in Staphylococcus aureus Bacteremia? A Protocol for the Adjunctive Treatment Domain of the Staphylococcus aureus Network Adaptive Platform (SNAP) Randomized Controlled Trial
September 26, 2024
doi: 10.1093/cid/ciae289
Journal Of Infection
Infectious Disease
Platform
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
August 29, 2024
DOI: 10.1016/j.jinf.2024.106248
Journal Of Infection
Infectious Disease
COVID-19
Platform
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
April 30, 2024
doi: 10.1016/j.jinf.2024.106130. Epub 2024 Feb 29.
JACC
Infectious Disease
Platform
Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19
January 26, 2024
DOI: 10.1016/j.jacadv.2023.100780
The New England Journal of Medicine
Infectious Disease
COVID-19
Platform
Simvastatin in Critically Ill Patients with Covid-19
December 21, 2023
doi: 10.1056/NEJMoa2309995.
JAMA
Infectious Disease
COVID-19
Platform
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
December 16, 2023
doi:10.1001/jama.2022.23257